The notion “diabetes” refers to a disease impacting the body’s ability to produce/use insulin. At present, more than 365 million people suffer from the disease worldwide. By 2030, the figure may reach 550 million. Inappropriate eating habits combined with a sedentary lifestyle, growth of the diabetic population and an increase in the number of obesity cases are amid the main factors contributing to the diabetes market growth. The list of the products available on the market is extensive: continuous blood glucose meters, anti-diabetic drugs, insulin and insulin pumps, artificial pancreas devices, etc.
Evaluated at over USD 19.8 billion, North America represents the top market, while Europe acts as the second largest player. The global diabetes market is expected to be at approximately USD 100 billion in 2018, showing a twofold increase if compared to 2011.
The Catalogue includes research reports dedicated to the diabetes market. The studies describe past and current industry trends, disclose data on the market competition and profile top industry behemoths. Information on the upcoming market events, industry growth drivers and hindrances can be found in the reports, too. Besides, the research reports contain evaluation of the actual economic situation, analyses of the market prospects.
Publications found:
108
Sort by:
Diabetic Socks Market Size, Share & Trends Analysis Report By Product (Ankle Length, Calf Length, Knee Length), By Distribution Channel (Hypermarkets, E-commerce), By Region, And Segment Forecasts, 2020 - 2027
US$ 2,950.00
This report can be delivered to the clients within 48 Business Hours Diabetic Socks Market Growth & Trends The global diabetic socks market size is anticipated to reach USD 303.2 million by 2027, ac...
August 2020
80 pages
Pre-Diabetes Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2020
US$ 2,500.00
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2018 SUMMARY GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2018' provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report ...
March 2020
388 pages
Diabetic Nephropathy Global Clinical Trials Review, H1, 2020
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
March 2020
404 pages
Diabetic Macular Edema Global Clinical Trials Review, H1, 2020
US$ 2,500.00
... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...
March 2020
421 pages
Diabetes Devices Market Size, Share & Trends Analysis Report By Product (BGM Devices, Insulin Delivery Devices) By Distribution Channel, By End Use (Hospitals, Homecare), By Region, And Segment Forecasts, 2020 - 2027
US$ 5,950.00
The global diabetes devices market size is expected to reach USD 35.5 billion by 2024, according to a new report by Grand View Research, Inc. The market is projected to ... were obese. Some of the key companies in the global diabetes devices market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, ...
March 2020
110 pages
Diabetic Retinopathy Global Clinical Trials Review, H1, 2020
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
February 2020
330 pages
Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2020
US$ 2,500.00
... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...
January 2020
248 pages
The 2021-2026 World Outlook for Colorectal Cancer Drugs
US$ 995.00
This study covers the world outlook for colorectal cancer drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for colorectal cancer drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
November 2019
299 pages
China Diabetes Market Report: 2019-2024
US$ 1,999.00
... growth rates in the more developed markets have declined. According to the latest report by IMARC Group, titled “China Diabetes Market Report: 2019-2024”, the China diabetes market reached a value of US$ 3.37 Billion in 2018 ...
June 2019
92 pages
Diabetes Insipidus Global Clinical Trials Review, H1, 2019
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
May 2019
51 pages
Diabetic Complications Global Clinical Trials Review, H1, 2019
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
May 2019
1474 pages
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2019
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
May 2019
79 pages
Diabetic Hypertension Global Clinical Trials Review, H1, 2019
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
May 2019
43 pages
Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2019
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
May 2019
56 pages
Diabetic Neuropathy Global Clinical Trials Review, H1, 2019
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
May 2019
323 pages
Type 1 Diabetes: Epidemiology Forecast to 2026
US$ 3,995.00
Type 1 Diabetes: Epidemiology Forecast to 2026 SUMMARY Type 1 diabetes, formerly referred to as insulin-dependent diabetes, is a type of diabetes that predominantly develops ... The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of type 1 diabetes segmented by age (ages under ...
April 2019
29 pages
Japan Diabetes Market Report: 2019-2024
US$ 1,999.00
... of 4.4% during 2011-2018. The market is further projected to cross US$ 5 Billion by 2024, growing at a CAGR of 3.8% during 2019-2024. Diabetes refers to a chronic disease in which ... in the industry. Key Questions Answered in This Report: How has the Japan diabetes market performed so far and how will it perform ...
April 2019
89 pages
Global Type 2 Diabetes Treatment Market Research and Forecast, 2018-2023
US$ 3,600.00
... treatment therapies for diabetes and a strict regulatory framework that hamper the growth of the global type 2 diabetes market. Based on the region, the global type 2 diabetes ... of the World. North America dominates the global type 2 diabetes market owing to technological advancements and supportive government ...
January 2019
Diabetic Foot Ulcer (DFU) Market & Drug Pipeline Analysis - Forecast to 2025
US$ 4,950.00
“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The ... research for DFU. Market Data Forecasting model for DFU market DFU market dynamics DFU Market Sizing DFU related deals & Funding scenario in DFU market Pipeline Analysis ...
December 2018
136 pages
Type 1 Diabetes: Competitive Landscape to 2026
US$ 3,495.00
Type 1 Diabetes: Competitive Landscape to 2026 SUMMARY Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells ... impact the global Type 1 Diabetes (T1D) market in the future. Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing ...
September 2018
48 pages
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018
US$ 3,995.00
... provides an overview of the pipeline landscape for diabetes and associated metabolic conditions. It provides comprehensive information on the therapeutics ... targets acted on by products in development for diabetes and associated metabolic conditions include the insulin receptor, glucagon-like peptide 1 ...
June 2018
344 pages
U.S. Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (Inhalable Insulin, Oral Insulin, Insulin Patch, CGM System, and Artificial Pancreas), Demographic (Adult Population and Child Population), Indication (Type I Diabetes and Type II Diabetes), and End User (Diagnostics/Clinic, ICU, and Home Healthcare) - U.S. Opportunity Analysis and Industry Forecast, 2014-2023
US$ 3,255.00
... skin irritation due to frequent use of needles. The U.S. next generation diabetes therapy and drug delivery market is segmented based on product type, ... analysis of the key developments in the industry. The U.S. next generation diabetes therapy and drug delivery market is comprehensively analyzed with respect to ...
April 2018
124 pages
Type 2 Diabetes: Competitive Landscape to 2026
US$ 3,495.00
Type 2 Diabetes: Competitive Landscape to 2026 SUMMARY Type 2 Diabetes (T2D) is a chronic disease characterized by insulin resistance and ... impact the global Type 2 Diabetes (T2D) market in the future. Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing ...
March 2018
51 pages
Global Human Insulin Market 2018-2024
US$ 2,750.00
... for the manufacturers of human insulin. Market Analysis: The “Global Human Insulin” market is estimated to witness a CAGR of 10.2% during the forecast period 2017–2023. The human insulin market is analyzed based on three ...
February 2018
77 pages
Medical Affairs Reputations: Type 2 Diabetes Mellitus [Orals] (EU5) 2018
US$ 6,365.00
... the market leader In the EU5, several of the Type 2 Diabetes Mellitus medical affairs teams we surveyed are running neck and neck with ... ways you can improve your medical affair services in Medical Affairs Reputations: Type 2 Diabetes Mellitus (Orals) (EU5). Comparing 9 major Type 2 Diabetes Mellitus (Orals) ...
January 2018
India Diabetes Market Report 2017
US$ 2,350.00
... still maintained a relatively optimistic growth, the past four years, Diabetes market size to maintain the average annual growth rate of 1.96% from 401 ... ) Channel (Direct Sales, Distributor) Segmentation Section 7: 400 USD - Trend (2017-2021) Section 8: 300 USD - Product Type Detail Section 9: 700 ...
November 2017
126 pages
NPS+ Type 2 Diabetes Mellitus [2017] EU5
US$ 2,575.00
... does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (EU5) gives a unique insight into the overall brand health ... degludec/liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (EU5) offers valuable insight into brand loyalty from ...
August 2017
NPS+ Type 2 Diabetes Mellitus [2017] US
US$ 2,575.00
... how does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (US) gives a unique insight into the overall brand health of ... (liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (US) offers valuable insight into brand loyalty from the ...
August 2017
Gestational Diabetes Global Clinical Trials Review, H2, 2017
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
August 2017
133 pages
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017
US$ 2,500.00
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017 SUMMARY GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017' provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report ...
August 2017
283 pages
Diabetic Hypertension Global Clinical Trials Review, H2, 2017
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
July 2017
41 pages
Diabetic Complications Global Clinical Trials Review, H2, 2017
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
July 2017
1098 pages